BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 548940)

  • 1. Serum and sputum levels of cefaclor.
    Simon C; Gatzemeier U
    Postgrad Med J; 1979; 55 Suppl 4():30-4. PubMed ID: 548940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparative pharmacokinetics of oral cephalosporins: cephalexin, cefaclor and cefadroxil (author's transl)].
    Lode H; Stahlmann R; Dzwillo G; Koeppe P
    Arzneimittelforschung; 1980; 30(3):505-9. PubMed ID: 7387765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro activity and pharmacokinetics of cefaclor in normal volunteers and patients with renal failure.
    Levison ME; Santoro J; Agarwal BN
    Postgrad Med J; 1979; 55 Suppl 4():12-6. PubMed ID: 548939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of acute bronchitis and pneumonia with cefaclor.
    Mattson K; Renkonen OV; Laitinen L; Nikander-Hurme R
    Postgrad Med J; 1979; 55 Suppl 4():59-61. PubMed ID: 398482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pharmacokinetics of the oral cephalosporins cefaclor, cephradine and cephalexin.
    Welling PG; Dean S; Selen A; Kendall MJ; Wise R
    Int J Clin Pharmacol Biopharm; 1979 Sep; 17(9):397-400. PubMed ID: 500261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of acute bacterial bronchitis and pneumonia with cefaclor.
    Mogabgab WJ; Pollock B; Beville RB; Gentry LO; Jemsek JG
    Postgrad Med J; 1979; 55 Suppl 4():62-6. PubMed ID: 44908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Penetration of cefaclor to adenoid tissue and middle ear fluid in secretory otitis media.
    Edén T; Anari M; Ernstson S; Sundberg L
    Scand J Infect Dis Suppl; 1983; 39():48-52. PubMed ID: 6580733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cefaclor and amoxycillin in the treatment of infective exacerbations of chronic bronchitis.
    Law MR; Holt HA; Reeves DS; Hodson ME
    J Antimicrob Chemother; 1983 Jan; 11(1):83-8. PubMed ID: 6337988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Fundamental and clinical studies on S6472 (a new prolonged acting preparation of cefaclor) in the urological field].
    Kamidono S; Fujii A; Harada M; Arakawa S; Umezu K; Kataoka N; Ishigami J; Hirooka K; Shimatani N; Matsushita M
    Jpn J Antibiot; 1985 Mar; 38(3):869-904. PubMed ID: 3928939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cefaclor therapy in acute exacerbations of chronic bronchitis.
    Wernstedt L; Berntsson E; Thiringer G
    Postgrad Med J; 1979; 55 Suppl 4():56-8. PubMed ID: 548943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pharmacokinetics of cefaclor and initial therapeutical experience (author's transl)].
    Lode H; Köppe P; Stahlmann R
    Infection; 1979; 7 Suppl 6():600-5. PubMed ID: 551086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral cefaclor for treatment of bronchitis--a comparative double-blind study versus amoxycillin.
    Beumer HM; Veldkamp J
    Int J Clin Pharmacol Ther Toxicol; 1982 Mar; 20(3):113-7. PubMed ID: 7068283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Penetration of cefaclor into bronchial mucosa.
    Marlin GE; Nicholls AJ; Funnell GR; Bradbury R
    Thorax; 1984 Nov; 39(11):813-7. PubMed ID: 6505987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biliary excretion of cefaclor. Experimental and clinical study.
    Brogard JM; Pinget M; Comte F; Adloff M; Lavillaureix J
    Chemotherapy; 1982; 28(3):189-99. PubMed ID: 7094660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical studies on te concentration of cefaclor in sera and lung tissues of patients with respiratory diseases].
    Imaizumi M; Kajita M; Fujita K; Niimi T; Kamiya I; Takahashi T; Asaoka M; Abe T
    Jpn J Antibiot; 1986 Oct; 39(10):2754-60. PubMed ID: 3806958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cefaclor in the treatment of susceptible infections in infants and children.
    Rodriguez WJ; Ross S; Schwartz R; Goldenberg R; Khan W
    Postgrad Med J; 1979; 55 Suppl 4():35-8. PubMed ID: 548941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Report of experiences with the oral cephalosporin-derivative cephaclor in respiratory tract infections].
    Spath P
    Wien Med Wochenschr; 1983 Jan; 133(1):27-30. PubMed ID: 6837048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pharmacological and clinical studies on the long acting cefaclor (S6472)].
    Fujimoto M; Sakai K; Ueda T; Doi S; Sasaki T; Morimoto Y; Sawada A; Masada A
    Jpn J Antibiot; 1985 Mar; 38(3):849-57. PubMed ID: 3897612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cefaclor: clinical and bacteriological evaluation in 45 cases.
    Gómez-Lus R; Martinez-Piriz R; Espinosa C; Guillen G; Gómez-Agudo G; Clavel A
    Postgrad Med J; 1979; 55 Suppl 4():70-1. PubMed ID: 44909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of cefaclor.
    Derry JE
    Am J Hosp Pharm; 1981 Jan; 38(1):54-8. PubMed ID: 7011003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.